Vasomotor Symptoms During Menopause May Up Risk for Type 2 Diabetes

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 1, 2024.

By Elana Gotkine HealthDay Reporter

FRIDAY, Nov. 1, 2024 -- Vasomotor symptoms (VMS) during the menopause transition (MT) are associated with an increased risk for type 2 diabetes (T2D), according to a research letter published online Oct. 31 in JAMA Network Open.

Monique M. Hedderson, Ph.D., from Kaiser Permanente in Pleasanton, California, and colleagues examined the associations of frequency and trajectories of VMS with incident T2D over the MT in the Study of Women's Health Across the Nation. A total of 2,761 premenopausal or early perimenopausal women were assessed at up to 13 approximately annual follow-up visits.

At baseline, 28, 10, and 62 percent of women reported VMS on one to five days per two-week period, VMS on six or more days per week, and no VMS, respectively. Overall, 12.2 percent developed diabetes during follow-up. The researchers observed an association for more frequent time-varying VMS with an increased risk for incident diabetes (hazard ratios, 1.45 and 1.30 for frequent and infrequent VMS, respectively, versus no VMS), after adjustment for covariates. There were four trajectories of VMS: consistently low probability of VMS (26 percent), persistently high probability of VMS (31 percent), early onset-initial high probability that decreased over time (25 percent), and late onset-initial low probability that increased over time (19 percent); 0.2 percent of patients had unknown trajectory. Compared with women with consistently low VMS, those with persistently high VMS had an increased risk for diabetes (hazard ratio, 1.50).

"Women with frequent and/or persistent VMS over the MT may represent a high-risk group to target for diabetes prevention," the authors write.

One author disclosed ties to the pharmaceutical industry.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-11-02 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords